← Back to Clinical Trials
Recruiting NCT06849206

NCT06849206 Pennington Generation Cohort

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06849206
Status Recruiting
Phase
Sponsor Pennington Biomedical Research Center
Condition Obesity Prevention
Study Type OBSERVATIONAL
Enrollment 3,000 participants
Start Date 2025-02-24
Primary Completion 2045-02-24

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 3,000 participants in total. It began in 2025-02-24 with a primary completion date of 2045-02-24.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The Pennington Generation Cohort is an observational study comprised of Louisiana families. Families will be assessed at baseline for a variety of traits and behaviors, and then followed up over time to try to understand the role of lifestyle and the environment on the risk of developing obesity and other health outcomes.

Eligibility Criteria

Inclusion Criteria: * Children, adolescents, and young adults (birth through age 24 years) and their nuclear family members\* and adults age 25+ who are expectant parents or are trying to conceive * Self-reported resident of Louisiana * Ability to understand instructions and complete all study procedures * Able to provide informed consent (adults aged over 18 years) * Able to provide assent (children 9 to 17 years) * Able to communicate (oral and written) in English Exclusion Criteria: * Discretion of the Medical Monitor or Principal Investigator

Contact & Investigator

Central Contact

Peter T Katzmarzyk, PhD

✉ peter.katzmarzyk@pbrc.edu

📞 225-763-2536

Principal Investigator

Peter T Katzmarzyk, PhD

PRINCIPAL INVESTIGATOR

Pennington Biomedical Research Center

Frequently Asked Questions

Who can join the NCT06849206 clinical trial?

This trial is open to participants of all sexes, studying Obesity Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06849206 currently recruiting?

Yes, NCT06849206 is actively recruiting participants. Contact the research team at peter.katzmarzyk@pbrc.edu for enrollment information.

Where is the NCT06849206 trial being conducted?

This trial is being conducted at Baton Rouge, United States.

Who is sponsoring the NCT06849206 clinical trial?

NCT06849206 is sponsored by Pennington Biomedical Research Center. The principal investigator is Peter T Katzmarzyk, PhD at Pennington Biomedical Research Center. The trial plans to enroll 3,000 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology